Company:  ALTIMMUNE, INC. (ALT)
Form Type:  4
Filing Date:  9/14/2018 
CIK:  0001326190 
Address:  910 CLOPPER ROAD
SUITE 201S
 
City, State, Zip:  GAITHERSBURG, Maryland 20878 
Telephone:  (240) 654-1450 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$4.47  
Change: 
-0.18 (-3.87%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$30.79M
Trade ALT now with 

© 2018  
Description of Business
Altimmune, Inc. is a clinical stage immunotherapeutics company focused on the development of products to stimulate robust and durable immune responses for the prevention and treatment of diseases. We have two proprietary platform technologies, RespirVec and Densigen, each of which has been shown, in preclinical studies and early clinical trials, to activate the immune system in distinctly different ways than traditional vaccine methods. Using these technologies, we have generated clinical product candidates which potentially represent an entirely new approach to harnessing the immune system. We have two programs using the Respirvec recombinant adenovirus technology. NasoVAX, an intranasally administered recombinant influenza vaccine, uses an adenovector to achieve expression of the influenza antigen in the target cell, thereby potentially stimulating a broader and more rapid immune response than traditional influenza vaccines.
Register and access this filing in:     
  FORM 4
    NAME AND TITLE
    NON DERIVATIVE SECURITIES
    DERIVATIVE SECURITIES
    EXPLANATIONS AND REMARKS
    REPORTING OWNERS
    SIGNATURES